Quarterly report · Q2

Period2023-01-21 → 2023-07-20
Filed2023-09-01
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥101.7bn2023-01-21 → 2023-07-20Cons.Net sales
Revenue¥160.1bn2022-01-21 → 2023-01-20Cons.Net sales (5-year summary)
Revenue¥79.8bn2022-01-21 → 2022-07-20Cons.Net sales
Operating income¥2.5bn2023-01-21 → 2023-07-20Cons.Operating income
Operating income¥723m2022-01-21 → 2022-07-20Cons.Operating income
Ordinary income¥1.8bn2023-01-21 → 2023-07-20Cons.Ordinary income
Ordinary income¥591m2022-01-21 → 2023-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥461m2022-01-21 → 2022-07-20Cons.Ordinary income
Profit before tax¥4.1bn2023-01-21 → 2023-07-20Cons.Income before income taxes
Profit before tax¥351m2022-01-21 → 2022-07-20Cons.Income before income taxes
Net income (owners)¥2.3bn2023-01-21 → 2023-07-20Cons.Profit loss attributable to owners of parent
Net income (owners)−¥507m2022-01-21 → 2023-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥869m2022-01-21 → 2022-07-20Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2023-01-21 → 2023-07-20Cons.Profit loss
Net income−¥909m2022-01-21 → 2022-07-20Cons.Profit loss
Total assets¥182.1bnat 2023-07-20Cons.Assets
Total assets¥164.2bnat 2023-01-20Cons.Assets
Total assets¥170.3bnat 2022-07-20Cons.Total assets (5-year summary)
Total liabilities¥94.3bnat 2023-07-20Cons.Liabilities
Total liabilities¥80.1bnat 2023-01-20Cons.Liabilities
Net assets / equity¥87.8bnat 2023-07-20Cons.Net assets
Net assets / equity¥84.1bnat 2023-01-20Cons.Net assets
Net assets / equity¥84.3bnat 2022-07-20Cons.Net assets (5-year summary)
Cash and deposits¥30.0bnat 2023-07-20Cons.Cash and deposits
Cash and deposits¥27.2bnat 2023-01-20Cons.Cash and deposits
Cash & equivalents¥33.0bnat 2023-07-20Cons.Cash and cash equivalents
Cash & equivalents¥29.2bnat 2023-01-20Cons.Cash and cash equivalents
Cash & equivalents¥28.8bnat 2022-07-20Cons.Cash and cash equivalents
Cash & equivalents¥30.1bnat 2022-01-20dCons.Cash and cash equivalents
Operating cash flow¥2.7bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in operating activities
Operating cash flow¥5.1bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥423m2022-01-21 → 2022-07-20Cons.Net cash provided by used in operating activities
Investing cash flow¥1.4bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.0bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.8bn2022-01-21 → 2022-07-20Cons.Net cash provided by used in investment activities
Financing cash flow−¥50m2023-01-21 → 2023-07-20Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.1bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.7bn2022-01-21 → 2022-07-20Cons.Net cash provided by used in financing activities
EPS (basic)¥149.292023-01-21 → 2023-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥168.122023-04-21 → 2023-07-20dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.42022-01-21 → 2023-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-55.542022-01-21 → 2022-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.772022-04-21 → 2022-07-20dCons.Basic earnings loss per share (5-year summary)
Equity ratio47.2%at 2023-07-20Cons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio49.3%at 2022-07-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingrevenue intersegment2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingsegment profit2023-01-21 → 2023-07-20−¥502m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥74.3bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥74.2bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥19m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥1.8bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2023-01-21 → 2023-07-20−¥296m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥3m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥776m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥462m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥6.4bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥6.2bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥180m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥239m
—segment totalrevenue2023-01-21 → 2023-07-20¥102.0bn
—segment totalrevenue external2023-01-21 → 2023-07-20¥101.7bn
—segment totalrevenue intersegment2023-01-21 → 2023-07-20¥204m
—segment totalsegment profit2023-01-21 → 2023-07-20¥3.0bn
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-07-20−¥302m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-07-20−¥302m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-07-20−¥615m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥54.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥54.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥21m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥1.4bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-07-20−¥269m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥4m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥908m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥9.3bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥9.3bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-07-20−¥735m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥6.0bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥5.7bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥276m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥66m
—segment totalrevenue2022-01-21 → 2022-07-20¥80.1bn
—segment totalrevenue external2022-01-21 → 2022-07-20¥79.8bn
—segment totalrevenue intersegment2022-01-21 → 2022-07-20¥302m
—segment totalsegment profit2022-01-21 → 2022-07-20¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 564
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember2470000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1554
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember2011000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1265
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1093000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0688
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember630000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0396
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember495000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0311
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember495000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0311
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember494000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0310
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember250000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0157
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember223000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0140
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember207000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0130
Number of shares heldCurrentQuarterInstant8371000
Shareholding ratioCurrentQuarterInstant0.5266
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember673600
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember2000
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember15875800
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember158758
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember17100
Number of shares issued shares voting rightsCurrentQuarterInstant16568500
Number of voting rights issued shares voting rightsCurrentQuarterInstant158758
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member673600
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member673600
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0406
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row2Member2000
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row2Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row2Member2000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row2Member0.0001
Number of shares held in own name treasury shares etcCurrentQuarterInstant675600
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant675600
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0407
Cash and depositsPrior1YearInstant27180000000JPY
Cash and depositsCurrentQuarterInstant30038000000JPY
Notes and accounts receivable tradePrior1YearInstant18818000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant26963000000JPY
Short term investment securitiesPrior1YearInstant17100000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-01-20pass
balance sheet identityconsolidated 2023-07-20pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-01-20pass
statement vs summary · net assetsconsolidated 2023-07-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-07-20pass
statement vs summary · net income attributable to parentconsolidated 2023-01-21/2023-07-20pass
statement vs summary · operating cash flowconsolidated 2022-01-21/2022-07-20pass
statement vs summary · operating cash flowconsolidated 2023-01-21/2023-07-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-07-20pass
statement vs summary · revenueconsolidated 2023-01-21/2023-07-20pass
statement vs summary · total assetsconsolidated 2023-01-20pass
statement vs summary · total assetsconsolidated 2023-07-20pass